MHC-peptide-specific antibodies reveal inefficient presentation of an HLA-A*0201-restricted, Melan-A-derived peptide after active intracellular processing.

Similar Items

• MHC-peptide-specific antibodies reveal inefficient presentation of an HLA-A*0201-restricted, Melan-A-derived peptide after active intracellular processing (vol 37, pg 2008, 2007)
  by: Held, G, et al.
  Published: (2008)
• Erratum: MHC-peptide-specific antibodies reveal inefficient presentation of an HLA-A*0201-restricted, Melan-A-derived peptide after active intracellular processing (European Journal of Immunology (2007) vol. 37 (7) 10.1002/eji.200636545)
  by: Held, G, et al.
  Published: (2008)
• Differences in phenotype and function between spontaneously occurring melan-A-, tyrosinase- and influenza matrix peptide-specific CTL in HLA-A*0201 melanoma patients.
  by: Maczek, C, et al.
  Published: (2005)
• Analysis of the cytolytic T lymphocyte response of melanoma patients to the naturally HLA-A*0201-associated tyrosinase peptide 368-376.
  by: Valmori, D, et al.
  Published: (1999)
• The quantity of naturally processed peptides stably bound by HLA-A*0201 is significantly reduced in the absence of tapasin.
  by: Barber, L, et al.
  Published: (2001)